Gilmore Neil O'neill - Net Worth and Insider Trading
Gilmore Neil O'neill Net Worth
The estimated net worth of Gilmore Neil O'neill is at least $383,890 dollars as of 2024-12-27. Gilmore Neil O'neill is the CEO of Editas Medicine Inc and owns about 312,106 shares of Editas Medicine Inc (EDIT) stock worth over $383,890. Details can be seen in Gilmore Neil O'neill's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gilmore Neil O'neill has not made any transactions after 2024-12-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gilmore Neil O'neill
Gilmore Neil O'neill Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gilmore Neil O'neill owns 4 companies in total, including Sarepta Therapeutics Inc (SRPT) , Unity Biotechnology Inc (UBX) , and Aptinyx Inc (APTX) among others .
Click here to see the complete history of Gilmore Neil O'neill’s form 4 insider trades.
Insider Ownership Summary of Gilmore Neil O'neill
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SRPT | Sarepta Therapeutics Inc | 2018-06-07 | SVP & Chief Medical Officer |
UBX | Unity Biotechnology Inc | 2020-12-10 | director |
APTX | Aptinyx Inc | 2021-10-19 | director |
2024-12-03 | director & CEO |
Gilmore Neil O'neill Latest Holdings Summary
Gilmore Neil O'neill currently owns a total of 1 stock. Gilmore Neil O'neill owns 312,106 shares of Editas Medicine Inc (EDIT) as of December 3, 2024, with a value of $383,890.
Latest Holdings of Gilmore Neil O'neill
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
EDIT | Editas Medicine Inc | 2024-12-03 | 312,106 | 1.23 | 383,890 |
Holding Weightings of Gilmore Neil O'neill
Gilmore Neil O'neill Form 4 Trading Tracker
According to the SEC Form 4 filings, Gilmore Neil O'neill has made a total of 5 transactions in Editas Medicine Inc (EDIT) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Editas Medicine Inc is the sale of 1,618 shares on December 3, 2024, which brought Gilmore Neil O'neill around $3,365.
Insider Trading History of Gilmore Neil O'neill
- 1
Gilmore Neil O'neill Trading Performance
Gilmore Neil O'neill Ownership Network
Gilmore Neil O'neill Owned Company Details
What does Sarepta Therapeutics Inc do?
Who are the key executives at Sarepta Therapeutics Inc?
Gilmore Neil O'neill is the SVP & Chief Medical Officer of Sarepta Therapeutics Inc. Other key executives at Sarepta Therapeutics Inc include Chief Financial Officer Ian Michael Estepan , Chief Tech Ops Officer Bilal Arif , and SVP & General Counsel Ryan Edward Brown .
Sarepta Therapeutics Inc (SRPT) Insider Trades Summary
Over the past 18 months, Gilmore Neil O'neill made no insider transaction in Sarepta Therapeutics Inc (SRPT). Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net purchase of 105,570 shares made by Michael Andrew Chambers , a net sale of 40,500 shares made by Wigzell Hans Lennart Rudolf , and a net sale of 40,957 shares made by Ryan Edward Brown .
In summary, during the past 3 months, insiders sold 12,136 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 0 shares, with a net sale of 12,136 shares. During the past 18 months, 111,566 shares of Sarepta Therapeutics Inc (SRPT) were sold and 180,795 shares were bought by its insiders, resulting in a net purchase of 69,229 shares.
Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sarepta Therapeutics Inc Insider Transactions
Gilmore Neil O'neill Mailing Address
Above is the net worth, insider trading, and ownership report for Gilmore Neil O'neill. You might contact Gilmore Neil O'neill via mailing address: 215 First Street, Cambridge Ma 02142.